Emerald Mutual Fund Advisers Trust’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-76,993
| Closed | -$7.16M | – | 238 |
|
|
2021
Q4 | $7.16M | Sell |
76,993
-92,431
| -55% | -$6.09M | 0.25% | 111 |
|
|
2021
Q3 | $10.1M | Sell |
169,424
-121,109
| -42% | -$7.15M | 0.35% | 90 |
|
|
2021
Q2 | $19.8M | Sell |
290,533
-5,505
| -2% | -$359K | 0.65% | 63 |
|
|
2021
Q1 | $20.5M | Sell |
296,038
-12,790
| -4% | -$984K | 0.68% | 64 |
|
|
2020
Q4 | $23.7M | Buy |
308,828
+198,677
| +180% | +$14.9M | 0.83% | 45 |
|
|
2020
Q3 | $8.24M | Buy |
+110,151
| New | +$7.34M | 0.37% | 85 |
|
|
2019
Q4 | – | Sell |
-281,577
| Closed | -$12.9M | – | 308 |
|
|
2019
Q3 | $12.9M | Sell |
281,577
-106,841
| -28% | -$6.01M | 0.57% | 58 |
|
|
2019
Q2 | $22.8M | Hold |
388,418
| – | – | 0.9% | 33 |
|
|
2019
Q1 | $17.4M | Buy |
388,418
+6,408
| +2% | +$294K | 0.7% | 49 |
|
|
2018
Q4 | $14.9M | Sell |
382,010
-9,500
| -2% | -$373K | 0.7% | 48 |
|
|
2018
Q3 | $18M | Sell |
391,510
-9,820
| -2% | -$398K | 0.61% | 59 |
|
|
2018
Q2 | $17.5M | Buy |
401,330
+16,880
| +4% | +$725K | 0.63% | 54 |
|
|
2018
Q1 | $15.2M | Buy |
+384,450
| New | +$15M | 0.6% | 57 |
|
Emerald Mutual Fund Advisers Trust's ARNA Position: Q1 2022 in Review
Emerald Mutual Fund Advisers Trust sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 76,993 shares — an estimated $7.16M sold.
Emerald Mutual Fund Advisers Trust first reported a position in ARNA in Q1 2018 and held it in 13 quarters. The position peaked at $23.7M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Emerald Mutual Fund Advisers Trust reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Emerald Mutual Fund Advisers Trust sold 76,993 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $7.16M.
- Emerald Mutual Fund Advisers Trust first reported a position in Arena Pharmaceuticals Inc in Q1 2018 and held it in 13 quarters.
- Emerald Mutual Fund Advisers Trust's Arena Pharmaceuticals Inc position peaked at $23.7M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q1 2022, filed 29 Apr 2022.